Degenerative Disc Disease Treatment Market, by Product Type (Drugs (Acetaminophen, NSAIDs, Oral Steroids, and Muscle Relaxants), Devices (Cervical Spine, Lumbar Spine, Thoracic Spine and Spinal Fusion), and by Region (North America, Latin America, Europe

Degenerative Disc Disease Treatment Market, by Product Type (Drugs (Acetaminophen, NSAIDs, Oral Steroids, and Muscle Relaxants), Devices (Cervical Spine, Lumbar Spine, Thoracic Spine and Spinal Fusion), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Degenerative disc disease is a spinal condition caused by the breakdown of intervertebral discs. The symptoms observed for degenerative disc disease are tingling or numbness in legs or difficulty walking. This disease is diagnosed with physical examination, through X-rays or magnetic resonance imaging (MRI). The degenerative disc disease is most commonly seen in geriatric population and have caused low back pain and neck pain in adults. The common cases of back pain among patients occurs at the lower side of the back. As per American Association of Neurological Surgeons in 2016, 75-85% of the people in the U.S. experience some form of back pain in their life.
Market Dynamics
Increasing prevalence of degenerative disc disease is expected to support the market growth over the forecast period. For instance, according to the National Center for Biotechnology Information report, around 266 million patients worldwide were diagnosed with lumbar degenerative spine disease (DSD) in 2021.
However, high cost associated with degenerative disc disease treatments such as artificial disc replacement and spinal fusion is expected to hamper the market growth in the near future. For instance, the average cost of specific disc replacement surgery procedure ranges between US$ 16,000 to US$ 46,000 in different states of the U.S.
Key features of the study:
This report provides in-depth analysis of the global degenerative disc disease treatment market, market size (US$ Mn), and compound annual growth rate (CAGR (%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global degenerative disc disease treatment market based on the following parameters: company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Medtronic Plc., Globus Medical Inc., Johnson & Johnson, Zimmer Biomet Holdings, Inc., B. Braun Melsungen AG, RTI Surgical Holdings, Inc., Cousin Biotech, Ulrich Medical USA, Inc., Fresenius Kabi AG and Abbott Laboratories
Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global Degenerative Disc Disease Treatment market report caters to various stakeholders in this industry, which include investors, product manufacturers, distributors, and suppliers for global Degenerative Disc Disease Treatment market, research and consulting firms, new entrants, and financial analysts.

Detailed Segmentation:
Global Degenerative Disc Disease Treatment Market, by Product Type:
Drugs
Acetaminophen
NSAIDs
Oral steroids
Muscle Relaxants
Devices
Cervical Spine
Lumbar Spine
Thoracic Spine
Spinal Fusion
Global Degenerative Disc Disease Treatment Market, by Region:
North America
By Country:
U.S.
Canada
By Product Type:
Drugs
Acetaminophen
NSAIDs
Oral steroids
Muscle Relaxants
Devices
Cervical Spine
Lumbar Spine
Thoracic Spine
Spinal Fusion
Europe
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
By Product Type:
Drugs
Acetaminophen
NSAIDs
Oral steroids
Muscle Relaxants
Devices
Cervical Spine
Lumbar Spine
Thoracic Spine
Spinal Fusion
Asia Pacific
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
By Product Type:
Drugs
Acetaminophen
NSAIDs
Oral steroids
Muscle Relaxants
Devices
Cervical Spine
Lumbar Spine
Thoracic Spine
Spinal Fusion
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
By Product Type:
Drugs
Acetaminophen
NSAIDs
Oral steroids
Muscle Relaxants
Devices
Cervical Spine
Lumbar Spine
Thoracic Spine
Spinal Fusion
Middle East
By Country:
GCC
Israel
Rest of Middle East
By Product Type:
Drugs
Acetaminophen
NSAIDs
Oral steroids
Muscle Relaxants
Devices
Cervical Spine
Lumbar Spine
Thoracic Spine
Spinal Fusion
Africa
By Country/Region:
South Africa
Central Africa
North Africa
By Product Type:
Drugs
Acetaminophen
NSAIDs
Oral steroids
Muscle Relaxants
Devices
Cervical Spine
Lumbar Spine
Thoracic Spine
Spinal Fusion
Company Profiles
Medtronic Plc.*
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Globus Medical Inc.
Johnson & Johnson
Zimmer Biomet Holdings, Inc.
B. Braun Melsungen AG
RTI Surgical Holdings, Inc.
Cousin Biotech
Ulrich Medical USA, Inc.
Fresenius Kabi AG
Abbott Laboratories
“*” marked represents similar segmentation in other categories in the respective section.